NCT07106372Not yet recruitingPhase 3
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
A Multi-center, Single-arm, Open-label Study to Evaluate the Safety and Efficacy of Stapokibatrt in Children With Atopic Dermatitis
Source: ClinicalTrials.gov · Last updated 6 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multi-center, single-arm, open-label phase 3 study to evaluate the safety, efficacy, Pharmacokinetics(PK) and immunogenicity of Stapokibatrt in children with Atopic Dermatitis.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- First submitted
- 5 Aug 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Keymed Biosciences Co.Ltd
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT07106372
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 240
- From 1 Sept 2025 to the primary completion date, 28 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planned major surgical procedure during the patient's participation in this study.
Other
- Any other circumstances in which the researcher deems not suitable to participate in this study.
Who the study is looking for
- Voluntarily participate in the continuing study and sign the written Informed Consent Form(ICF).
- Subjects who must complete the evaluation of Week 18 of the main study.
- Have the ability to communicate well with the researcher and comply with the follow-up visits of the protocol.
Age in the registry: 2 years to 12 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Children's Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.